These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4096874)

  • 1. Assessment of the aluminum overload and of its possible toxicity in asymptomatic uremic patients: evidence for a depressive effect on bone formation.
    Sebert JL; Marie A; Gueris J; Herve MA; Leflon P; Garabedian M; Smadja A; Fournier A
    Bone; 1985; 6(5):373-5. PubMed ID: 4096874
    [No Abstract]   [Full Text] [Related]  

  • 2. Aluminum localization in bone from hemodialyzed patients: relationship to matrix mineralization.
    Cournot-Witmer G; Zingraff J; Plachot JJ; Escaig F; Lefèvre R; Boumati P; Bourdeau A; Garabédian M; Galle P; Bourdon R; Drüeke T; Balsan S
    Kidney Int; 1981 Sep; 20(3):375-8. PubMed ID: 7300127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aluminum and uremic bone disease. Diagnostic utility of serum aluminum and the deferoxamine (DFO) test ].
    Jarava C; Armas JR; Palma A
    Nefrologia; 2001; 21(2):174-81. PubMed ID: 11464651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated bone aluminum content in dialysis patients without osteomalacia.
    McCarthy JT; Kurtz SB; McCall JT
    Mayo Clin Proc; 1985 May; 60(5):315-20. PubMed ID: 3990380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive diagnosis of uremic osteodystrophy: uses and limitations.
    Heaf JG; Joffe P; Pødenphant J; Andersen JR
    Am J Nephrol; 1987; 7(3):203-11. PubMed ID: 3631150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aluminum - related osteomalacia.
    Ott SM
    Int J Artif Organs; 1983 Jul; 6(4):173-5. PubMed ID: 6629522
    [No Abstract]   [Full Text] [Related]  

  • 7. [Osteomalacia as a result of aluminum poisoning during chronic hemodialysis].
    Cournot-Witmer G; Gagnadoux MF; Lebon P; Broyer M; Balsan S
    Arch Fr Pediatr; 1982 Dec; 39 Suppl 2():749-54. PubMed ID: 6762177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desferrioxamine therapy in hemodialysis patients with aluminum-associated bone disease.
    Felsenfeld AJ; Rodriguez M; Coleman M; Ross D; Llach F
    Kidney Int; 1989 Jun; 35(6):1371-8. PubMed ID: 2770115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathogenesis of renal osteodystrophy: role of vitamin D, aluminium, parathyroid hormone, calcium and phosphorus.
    Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Johnson JR; George CR; Collett P; Kalowski S
    Q J Med; 1985 May; 55(217):127-44. PubMed ID: 4001311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of bone aluminum content and bone histology in patients on chronic hemodialysis and hemofiltration.
    Sebert JL; Fournier A; Leflon P; Fohrer P; de Frémont JF; Morinière P; Galy C; Marie A; Demontis R; Boudailliez B
    Nephron; 1986; 42(1):34-40. PubMed ID: 3941748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid hormone in aluminum bone disease: a comparison of parathyroid hormone assays.
    Andress DL; Endres DB; Ott SM; Sherrard DJ
    Kidney Int Suppl; 1986 Feb; 18():S87-90. PubMed ID: 3458004
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of aluminum on bone and cell localization.
    Cournot-Witmer G; Plachot JJ; Bourdeau A; Lieberherr M; Jorgetti V; Mendes V; Halpern S; Hemmerle J; Drüeke T; Balsan S
    Kidney Int Suppl; 1986 Feb; 18():S37-40. PubMed ID: 3457993
    [No Abstract]   [Full Text] [Related]  

  • 13. Histomorphometric evidence of deleterious effect of aluminum on osteoblasts.
    de Vernejoul MC; Belenguer R; Halkidou H; Buisine A; Bielakoff J; Miravet L
    Bone; 1985; 6(1):15-20. PubMed ID: 2581595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of bone resulting from accumulation of aluminum in bone of patients undergoing dialysis.
    Faugere MC; Arnala IO; Ritz E; Malluche HH
    J Lab Clin Med; 1986 Jun; 107(6):481-7. PubMed ID: 3486929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic bone disease and aluminium contamination in 38 uremic patients. A bone histomorphometric study.
    Pødenphant J; Heaf JG; Joffe P
    Acta Pathol Microbiol Immunol Scand A; 1986 Jan; 94(1):1-6. PubMed ID: 3962676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteomalacia and bone disease arising from aluminum.
    Coburn JW; Norris KC; Nebeker HG
    Semin Nephrol; 1986 Mar; 6(1):68-89. PubMed ID: 3110896
    [No Abstract]   [Full Text] [Related]  

  • 18. Aluminum: culprit or accessory in the genesis of renal osteodystrophy.
    Quarles LD; Gitelman HJ; Drezner MK
    Semin Nephrol; 1986 Mar; 6(1):90-101. PubMed ID: 3299578
    [No Abstract]   [Full Text] [Related]  

  • 19. Aluminum and renal osteodystrophy in chronic uremia.
    Berland Y; Grandvuillemin M; Charhon S; Olmer M
    Kidney Int Suppl; 1985 Dec; 17():S183-7. PubMed ID: 3867793
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone aluminum and histomorphometric features of renal osteodystrophy.
    Hodsman AB; Sherrard DJ; Alfrey AC; Ott S; Brickman AS; Miller NL; Maloney NA; Coburn JW
    J Clin Endocrinol Metab; 1982 Mar; 54(3):539-46. PubMed ID: 7056841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.